Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,779 | 264 | 97.9% |
| Education | $79.99 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $837.66 | 41 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $678.29 | 104 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $291.57 | 27 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $273.60 | 14 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $230.14 | 12 | $0 (2023) |
| Lundbeck LLC | $181.33 | 9 | $0 (2024) |
| Allergan Inc. | $158.43 | 3 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $139.57 | 6 | $0 (2020) |
| Shire North American Group Inc | $135.26 | 7 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $106.79 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $465.06 | 22 | ABBVIE INC. ($286.73) |
| 2023 | $471.06 | 19 | AbbVie Inc. ($354.28) |
| 2022 | $388.26 | 17 | ABBVIE INC. ($134.84) |
| 2021 | $87.12 | 7 | AbbVie Inc. ($61.81) |
| 2020 | $129.87 | 6 | Janssen Pharmaceuticals, Inc ($42.78) |
| 2019 | $936.10 | 57 | Sunovion Pharmaceuticals Inc. ($191.99) |
| 2018 | $774.88 | 73 | Sunovion Pharmaceuticals Inc. ($198.94) |
| 2017 | $606.23 | 66 | Sunovion Pharmaceuticals Inc. ($243.06) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ADHD | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PSYCHIATRY | ||||||
| 01/29/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neurology | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 49 | 196 | $86,736 | $19,056 |
| 2022 | 1 | 49 | 205 | $79,950 | $15,296 |
| 2021 | 2 | 73 | 268 | $85,910 | $19,180 |
| 2020 | 3 | 130 | 323 | $41,806 | $16,899 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 196 | $86,736 | $19,056 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 205 | $79,950 | $15,296 | 19.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 228 | $74,677 | $17,425 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 40 | $11,233 | $1,755 | 15.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 152 | $23,788 | $10,108 | 42.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 153 | $16,218 | $5,934 | 36.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 14 | 18 | $1,800 | $856.08 | 47.6% |
About Dr. Robert Winston, M.D
Dr. Robert Winston, M.D is a Psychiatry healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992805444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Winston, M.D has received a total of $3,859 in payments from pharmaceutical and medical device companies, with $465.06 received in 2024. These payments were reported across 267 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,779).
As a Medicare-enrolled provider, Winston has provided services to 301 Medicare beneficiaries, totaling 992 services with total Medicare billing of $70,431. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Torrance, CA
- Active Since 09/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992805444
Products in Payments
- VRAYLAR (Drug) $996.09
- LATUDA (Drug) $678.29
- Trintellix (Drug) $373.53
- REXULTI (Drug) $249.95
- SPRAVATO (Drug) $182.11
- CAPLYTA (Drug) $166.86
- AUSTEDO (Drug) $139.57
- QUVIVIQ (Drug) $106.79
- INVEGA SUSTENNA (Drug) $91.49
- ARISTADA (Drug) $83.31
- Adzenys XR-ODT (Drug) $82.16
- VYVANSE (Drug) $80.43
- MYDAYIS (Drug) $76.08
- TRINTELLIX (Drug) $73.56
- ABILIFY MAINTENA (Drug) $63.74
- Hetlioz (Drug) $54.48
- APLENZIN (Drug) $47.88
- BELSOMRA (Drug) $41.91
- INGREZZA (Drug) $41.29
- Evekeo (Drug) $36.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Torrance
Dr. James Pratty, M.d, M.D
Psychiatry — Payments: $780,597
Dr. Lara Shirikjian, D.o, D.O
Psychiatry — Payments: $246,400
Dr. Isabel Puri, Md, MD
Psychiatry — Payments: $9,515
Dr. Kartik Ananth, Md, MD
Psychiatry — Payments: $6,700
Dr. David Ruderman, M.d, M.D
Psychiatry — Payments: $5,938
Dr. Min Kim, Do, DO
Psychiatry — Payments: $3,374